Contact Us

+350 20079000 info@hassans.gi

This data will only be used by Hassans for processing your query and for no other purpose. View our privacy policy

Time to pay attention to Psychedelic Medicine says The Motley Fool

As previously highlighted in other posts, investors should keep an eye out for stocks in the psychedelic medicine space. Mind Medecine, Compass Pathways and Field Trip Ventures are all candidates to go public in the next 12 months. 

Are we with psychedelic medicine where we were with cannabis 10-15 years ago?

What's important to understand is that a paradigm shift is starting to taking shape within the Western medical community. In effect, scientists are increasingly intrigued by the therapeutic potential of psychedelics as treatments for a whole range of mental health disorders. Pyschedelic medicine thus has the potential to be a gold mine for early investors. www.fool.com/...

Gibraltar Opens the Door to Tokenised Fund Shares: What It Means and Who Can Use It

DLT now sits inside Gibraltar's statutory framework for investment funds, a step most jurisdictions have discussed without legislating...

Posted on
Read more

Latest Insights

When “High Profits” Become a Political Problem – and Why Jurisdiction Stability Matters More Than Ever

BP's first-quarter 2026 profits doubled. Shell's rose by nearly a quarter. TotalEnergies posted a 51 per cent jump. The headlines wrote...

Posted on
Read more

Gibraltar Opens the Door to Tokenised Fund Shares: What It Means and Who Can Use It

DLT now sits inside Gibraltar's statutory framework for investment funds, a step most jurisdictions have discussed without legislating...

Posted on
Read more

OECD Side-by-Side Package: More Than Just a US Story

The latest episode of International Tax Bites sees myself and Harriet Brown unpack the OECD's recently released Side-by-Side Package and...

Posted on
Read more